Deregulation of IKBKE is associated with tumor progression, poor prognosis, and cisplatin resistance in ovarian cancer
American Journal Of Pathology (2009) - Comment
pubmed: 19497997  doi: 10.2353/ajpath.2009.080767  issn: 1525-2191  issn: 0002-9440 

Jian-Ping Guo, Shao-Kun Shu, Lili He, Yi-Chun Lee, Patricia A. Kruk, Seija Grenman, Santo V. Nicosia, Gil Mor, Michael J. Schell, Domenico Coppola, Jin Q. Cheng